CAMBRIDGE, Mass.--(BUSINESS WIRE)--Neurovance, Inc. today announced the appointment of Jeff Bailey as Executive Chairman of the Company’s Board of Directors. He brings nearly 30 years of experience from a wide range of earlier leadership positions. Mr. Bailey had previously been President and Chief Executive Officer of Lantheus Medical Imaging Inc. until August, 2015. Earlier, he served as Chief Operating Officer of Fougera Pharmaceuticals and Chief Commercial Officer for King Pharmaceuticals. He also held executive positions at Novartis Pharmaceuticals and Johnson and Johnson (and at the J&J subsidiary, Janssen Pharmaceuticals). Mr. Bailey earned a business degree from Rutgers University in New Jersey.
